| Generation and testing of clinical-grade exosomes for pancreatic cancer M Mendt, S Kamerkar, H Sugimoto, KM McAndrews, CC Wu, M Gagea, ... JCI insight 3 (8), 2018 | 622 | 2018 |
| Mesenchymal stem cell-derived exosomes for clinical use M Mendt, K Rezvani, E Shpall Bone marrow transplantation 54 (Suppl 2), 789-792, 2019 | 391 | 2019 |
| Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells M Daher, R Basar, E Gokdemir, N Baran, N Uprety, AK Nunez Cortes, ... Blood, The Journal of the American Society of Hematology 137 (5), 624-636, 2021 | 181 | 2021 |
| Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells H Shaim, M Shanley, R Basar, M Daher, J Gumin, DB Zamler, N Uprety, ... The Journal of Clinical Investigation 131 (14), 2021 | 149 | 2021 |
| Combining AFM13, a bispecific CD30/CD16 antibody, with cytokine-activated blood and cord blood–derived NK cells facilitates CAR-like responses against CD30+ malignancies LN Kerbauy, ND Marin, M Kaplan, PP Banerjee, MM Berrien-Elliott, ... Clinical Cancer Research 27 (13), 3744-3756, 2021 | 88 | 2021 |
| KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape Y Li, R Basar, G Wang, E Liu, JS Moyes, L Li, LN Kerbauy, N Uprety, ... Nature medicine 28 (10), 2133-2144, 2022 | 57 | 2022 |
| Stromal-derived factor-1 and its receptor, CXCR4, are constitutively expressed by mouse liver sinusoidal endothelial cells: implications for the regulation of hematopoietic … M Mendt, JE Cardier Stem Cells and Development 21 (12), 2142-2151, 2012 | 54 | 2012 |
| Large-scale GMP-compliant CRISPR-Cas9–mediated deletion of the glucocorticoid receptor in multivirus-specific T cells R Basar, M Daher, N Uprety, E Gokdemir, A Alsuliman, E Ensley, G Ozcan, ... Blood advances 4 (14), 3357-3367, 2020 | 30 | 2020 |
| Role of SDF-1 (CXCL12) in regulating hematopoietic stem and progenitor cells traffic into the liver during extramedullary hematopoiesis induced by G-CSF, AMD3100 and PHZ M Mendt, JE Cardier Cytokine 76 (2), 214-221, 2015 | 30 | 2015 |
| A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation L Li, H Chen, D Marin, Y Xi, Q Miao, J Lv, PP Banerjee, H Shaim, M Daher, ... Blood Advances 3 (23), 4117-4130, 2019 | 29 | 2019 |
| Evaluation of the potential of novel PCL–PPDX biodegradable scaffolds as support materials for cartilage tissue engineering IA Chaim, MA Sabino, M Mendt, AJ Müller, D Ajami Journal of tissue engineering and regenerative medicine 6 (4), 272-279, 2012 | 29 | 2012 |
| Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy R Basar, N Uprety, E Ensley, M Daher, K Klein, F Martinez, F Aung, ... Cell Reports 36 (3), 2021 | 28 | 2021 |
| The TGF-β/SMAD signaling pathway as a mediator of NK cell dysfunction and immune evasion in myelodysplastic syndrome M Daher, R Basar, H Shaim, E Gokdemir, N Uprety, A Kontoyiannis, ... Blood 130, 53, 2017 | 21 | 2017 |
| Activation of the CXCR4 chemokine receptor enhances biological functions associated with B16 melanoma liver metastasis M Mendt, JE Cardier Melanoma research 27 (4), 300-308, 2017 | 21 | 2017 |
| Metabolic reprogramming of GMP grade cord tissue derived mesenchymal stem cells enhances their suppressive potential in GVHD M Mendt, M Daher, R Basar, M Shanley, B Kumar, FL Wei Inng, S Acharya, ... Frontiers in immunology 12, 631353, 2021 | 18 | 2021 |
| Cord blood NK cells engineered to express a humanized CD123-targeted chimeric antigen receptor (CAR) and IL-15 as off-the-shelf therapy for acute myeloid leukemia LN Kerbauy, S Ang, E Liu, PP Banerjee, Y Wu, H Shaim, FLWI Lim, ... Blood 130 (Supplement 1), 4453-4453, 2017 | 17 | 2017 |
| Phase I study of mesenchymal stem cell (MSC)-derived exosomes with KRASG12D siRNA in patients with metastatic pancreatic cancer harboring a KRASG12D mutation. R Surana, VS LeBleu, JJ Lee, BG Smaglo, D Zhao, MS Lee, RA Wolff, ... Journal of Clinical Oncology 40 (4_suppl), TPS633-TPS633, 2022 | 14 | 2022 |
| RNAi technology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicine BC Parker Kerrigan, D Ledbetter, M Kronowitz, L Phillips, J Gumin, ... Neuro-Oncology Advances 2 (1), vdaa132, 2020 | 14 | 2020 |
| Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI insight. 2018 M Mendt, S Kamerkar, H Sugimoto, KM McAndrews, CC Wu, M Gagea, ... Preprint not peer reviewed Preprint not peer reviewed Preprint not peer …, 0 | 13 | |
| PAR1 expression predicts clinical G-CSF CD34+ HSPC mobilization and repopulation potential in transplanted patients N Nevo, T Zuckerman, S Gur-Cohen, O Kollet, F Avemaria, EJ Shpall, ... Hemasphere 3 (5), e288, 2019 | 5 | 2019 |
